Human Longevity, Inc.

Human Longevity, Inc. (HLI) is a genomics-based, health intelligence company striving to amass the world’s largest database of whole genome, phenotype, and clinical data. Utilizing large-scale computing and machine learning, HLI aims to derive personalized health insights and lead groundbreaking discoveries to extend healthy human life. Founded in 2013, the company operates within the Biotechnology and Health Care sectors, with its headquarters in the United States.

The company's mission revolves around the notion that while DNA plays a pivotal role in defining an individual's health, other influencing factors cannot be overlooked. Accordingly, HLI is dedicated to scrutinizing an extensive array of genotypic and phenotypic data to gain unparalleled insights. This perspective aims to expedite the comprehension of human attributes and behaviors, further propelling advancements for a healthier, better life.

Highlighting its recent $10.50M Venture Round investment secured on 06 April 2023, HLI stands as a compelling prospect for venture capital firms seeking involvement in the realm of healthtech and biotechnology.